The Study of Bemnifosbuvir in Healthy Japanese Subjects

Completed · Phase 1

Conditions studied: Healthy Volunteer Study

In brief

This study will assess the safety, tolerability and pharmacokinetics (PK) of Bemnifosbuvir in healthy adult Japanese subjects

Key facts

Study ID

NCT05905497

Run by

Atea Pharmaceuticals, Inc.

People needed

14

Starts

2023-04-26

Expected to finish

2023-05-19

Last updated by the study team

2023-06-15

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must agree to use two methods of birth control from Screening through 90 days after administration of the last dose of study drug
• Females must have a negative pregnancy test at Screening and prior to dosing
• Minimum body weight of 50 kg and body mass index (BMI) of 18-32 kg/m2
• Willing to comply with the study requirements and to provide written informed consent
• The subject must have been born in Japan and have both parents and 4 grandparents of Japanese descent
• The subject must have lived outside of Japan for no more than 10 years

You may not qualify if…

• Pregnant or breastfeeding
• Infected with hepatitis B virus, hepatitis C virus, HIV or COVID-19
• Abuse of alcohol or drugs
• Use of other investigational drugs within 28 days of dosing
• Other clinically significant medical conditions or laboratory abnormalities

Where it is running

• Atea Study Site — Cypress, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.